Mutual Advisors’s Organon & Co OGN Stock Holding History

Mutual Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,812	Closed	-$230K	–	921
2022 Q2	$230K	Sell	6,812 -399	-6%	-$14K	0.02%	750
2022 Q1	$252K	Sell	7,211 -295	-4%	-$10.1K	0.01%	761
2021 Q4	$229K	Sell	7,506 -421	-5%	-$13.7K	0.01%	805
2021 Q3	$260K	Sell	7,927 -261	-3%	-$8.35K	0.02%	749
2021 Q2	$248K	Buy	+8,188	New	+$270K	0.01%	733

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Mutual Advisors's OGN Position: Q3 2022 in Review

Mutual Advisors sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 6,812 shares — an estimated $230K sold.

Mutual Advisors first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $260K in Q3 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

Mutual Advisors reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
Mutual Advisors sold 6,812 Organon & Co shares in Q3 2022, an estimated $230K.
Mutual Advisors first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
Mutual Advisors's Organon & Co position peaked at $260K in Q3 2021.
791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Mutual Advisors's 13F filing for Q3 2022, filed 3 Nov 2022.